Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law
This article was originally published in The Gray Sheet
A new law makes vast changes to how clinical laboratory tests will be reimbursed by Medicare over the long term. Although the changes ultimately may lead to payment reductions, both test kits makers and laboratories applaud the new provisions. Reimbursement will better reflect the value that lab tests bring to the health care system, they say.
Register for our free email digests: